Tag Archives: Launch

Eli Lilly CEO’s pay grows—again—to $23.7M after COVID antibody launch, new approvals

The COVID-19 pandemic derailed plans for companies worldwide last year, but Eli Lilly adapted by developing medicines against the novel coronavirus—to the tune of $ 871 million in antibody revenue for Q4—while still pushing sales of its newer meds. Now, CEO David Ricks is reaping the rewards with a pay package that could place him… Read More »

Harvard Chan School, Apple, and NIH launch women’s health study

Harvard T.H. Chan School of Public Health, Apple, and the National Institutes of Health today launched the Apple Women’s Health Study. The large-scale longitudinal study, led by a team of researchers at Harvard Chan School, leverages participants’ voluntary use of a smartphone research app to advance understanding of menstrual and gynecological health. By making use… Read More »

Cancer researchers come to Harvard to share findings, launch center for early detection

Amid alarming projections that global cancer rates will skyrocket, researchers from around the country gathered at Harvard on Monday to share their latest findings and to launch a center whose aim is to boost early detection and prevention. By 2040, deaths due to cancer are expected to rise 60 percent in the U.S., 79 percent… Read More »

With Gamifant launch rolling, Sobi unveils more data backing the rare disease med

SAN DIEGO—Armed with last month’s FDA approval, Sobi is rolling out its newly minted rare disease drug Gamifant with a small, targeted sales force, and Monday it unveiled more of the data that won the agency’s favor in the first place. In a phase 2/3 trial of Gamifant in primary haemophagocytic lymphohistiocytosis (HLH), 64.7% of… Read More »